Jazz Pharmaceuticals plc (JAZZ) Discusses HERIZON-GEA-01 Phase III Trial Results for Zanidatamab in HER2+ GEA Transcript
Jazz Pharmaceuticals(US:JAZZ) Seeking Alpha·2026-01-09 19:24PresentationGood morning and welcome to the zanidatamab HERIZON-GEA-01 Investor Call and Webcast. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the call over to Renee Gala, President and Chief Executive Officer of Jazz Pharmaceuticals. Thank you. Please go ahead.Renée GaláPresident, CEO & Director Good morning, everyone. My name is Renee Gala, President and CEO of Jazz Pharmaceuticals. Thank you for joining us. Before I begin, please note that today' ...